|
Item
|
Case number (n = 71)
|
|---|
|
Age
|
59.21
|
|
Sex (male)
|
51
|
|
Underlying diseases n (%)
|
|
Bladder tumor
|
25 (35.21)
|
|
Kidney stone or tumor
|
12 (16.90)
|
|
Ureter stone or tumor
|
10 (14.08)
|
|
Cervical cancer
|
11 (15.49)
|
|
Other diseases
|
11 (15.49)
|
|
Department distribution n (%)
|
|
Urology surgery
|
47 (66.20)
|
|
Gynecology
|
11 (15.49)
|
|
Oncology
|
4 (5.63)
|
|
Other departments
|
9 (12.68)
|
|
Exposure operation
|
|
Invasive operation of urology
|
66 (92.96)
|
|
Rigid endoscope
|
32 (45.07)
|
|
Flexible endoscope
|
20 (28.17)
|
|
Resectoscope
|
7 (10.61)
|
|
Unrecorded endoscope
|
7 (10.61)
|
|
Bedside catheterization
|
5 (7.04)
|
|
Antimicrobial therapy
|
|
Quinolones
|
32 (45.07)
|
|
Carbapenems
|
18 (25.35)
|
|
Cephalosporins/others
|
11 (15.49)
|
|
Untreated
|
10 (14.08)
|
|
PFGE tested strains
|
20
|
|
PFGE homology strains
|
17
|
- Totals may be unequal to 100% due to rounding
- IPC infection prevention and control
